Heart Disease in Senior Yorkshire Terriers: Mitral Valve Disease Screening and Management

Understanding and managing mitral valve disease (MVD) in aging Yorkshire Terriers. Covers early detection through auscultation, staging, medical management, and quality of life optimization for Yorkies with cardiac disease.

By SeniorPetCare Research Published: July 4, 2026 Last updated: August 4, 2026

Quick Answer

Mitral valve disease is common in senior Yorkshire Terriers; routine auscultation and annual cardiac exams including echocardiography and chest radiographs help detect early murmur and stage disease. Management includes pimobendan, ACE inhibitors, diuretics as indicated, plus weight control, low sodium diet, exercise moderation, and regular rechecks to optimize quality of life. Early detection improves prognosis and treatment timing.

Article Summary — Key Takeaways

Reading time: 5 minutes | 6 key points

Point 1: MVD affects 75% of small breed dogs by age 16 Yorkies predisposed
Point 2: Annual cardiac screening starting at age 8 enables early detection
Point 3: Pimobendan at Stage B2 delays heart failure by median 15 months EPIC Trial
Point 4: Home monitoring of resting respiratory rate best early warning system
Point 5: Median survival after CHF is 9-12 months with optimal management
Point 6: Cough is most common sign of heart failure in small breeds

Heart Disease in Senior Yorkshire Terriers

[Mitral valve disease](https://seniorpet.org/knowledge/cavalier-king-charles-spaniel-mitral-valve-disease "Mitral Valve Disease Guide") (MVD) is the most common cardiac condition in small breed dogs, including Yorkshire Terriers. The mitral valve degenerates over time, allowing blood to leak backward (regurgitation), eventually leading to congestive heart failure if untreated.

Key Statistics & Research Data

MVD affects approximately 75% of small breed dogs by age 16 (Borgarelli & Buchanan, JVIM, 2012)
Yorkshire Terriers are among breeds with documented predisposition to MVD
Disease progression: average 3-5 years from murmur detection to heart failure (Borgarelli et al., JVIM, 2008)
ACVIM Stage B2 dogs benefit from [pimobendan](https://seniorpet.org/knowledge/pimobendan-vetmedin-heart-failure-guide "Pimobendan Heart Failure Guide"), delaying heart failure onset by median 15 months (EPIC Trial, 2016)
Median survival after CHF diagnosis: 9-12 months with optimal medical management (Häggström et al., JVIM, 2008)
Early detection through annual cardiac auscultation is recommended for all small breeds over age 8
Cough is the most common presenting sign, occurring in >80% of dogs with CHF

ACVIM Staging System

| Stage | Description | Action | |-------|-------------|--------| | A | At risk (breed predisposition) | Annual screening | | B1 | Murmur present, no enlargement | Monitor every 6-12 months | | B2 | Murmur + cardiac enlargement | Start pimobendan | | C | Current or past heart failure | Full medical management | | D | Refractory heart failure | Advanced/palliative care |

Early Detection

Screening Protocol for Senior Yorkies

Annual auscultation starting at age 8
Echocardiogram if murmur detected (confirms stage)
Chest radiographs to assess heart size and lung fields
Blood pressure measurement
NT-proBNP blood test (cardiac biomarker)

Early Warning Signs

New heart murmur on exam
Increased resting respiratory rate (>30 breaths/min)
Exercise intolerance or tiring easily
Coughing (especially at night or after rest)
Restlessness, difficulty settling

Medical Management

Stage B2 (Pre-clinical with enlargement)

Pimobendan (Vetmedin): Delays heart failure by median 15 months
Monitor resting respiratory rate at home
Echocardiogram every 6 months

Stage C (Heart failure)

Furosemide: Removes fluid from lungs
Pimobendan: Strengthens heart contraction
ACE inhibitor (enalapril/benazepril): Reduces afterload
Spironolactone: Additional diuretic + cardiac protection
Sodium-restricted diet
Activity modification

Home Monitoring

Resting Respiratory Rate (RRR)

Count breaths per minute while sleeping
Normal: <30 breaths/min
Concerning: >40 breaths/min (contact vet)
Emergency: >60 breaths/min

Key Takeaways

MVD affects 75% of small breed dogs by age 16 — Yorkshire Terriers are predisposed
Annual cardiac screening starting at age 8 enables early detection
Pimobendan at Stage B2 delays heart failure onset by median 15 months (EPIC Trial)
Home monitoring of resting respiratory rate is the best early warning system
With optimal management, median survival after CHF is 9-12 months
Cough is the most common sign of heart failure in small breeds

Frequently Asked Questions

When should my Yorkshire Terrier start cardiac screening?

Annual cardiac auscultation (listening for heart murmurs) is recommended for all small breed dogs starting at age 8. If a murmur is detected, echocardiography confirms the stage and guides treatment. For Yorkshire Terriers with a family history of heart disease, screening may start earlier. Between vet visits, monitor your Yorkie's resting respiratory rate at home — consistently above 30 breaths per minute while sleeping warrants veterinary evaluation.

What is the life expectancy for a Yorkshire Terrier with heart disease?

Prognosis depends heavily on the stage at diagnosis. Dogs detected at Stage B1 (murmur only, no enlargement) may live years before progression. At Stage B2, pimobendan delays heart failure by a median of 15 months (EPIC Trial, 2016). After congestive heart failure develops (Stage C), median survival is 9-12 months with optimal medical management. Early detection through annual screening and home respiratory rate monitoring gives the best outcomes.

Tracheal Collapse in Senior Yorkshire Terriers: Understanding and Managing This Breed-Defining Condition (yorkshire-terrier) — Senior Yorkshire Terriers commonly develop tracheal collapse, graded I–IV by degree of airway narrowing. Recognize a harsh “honking” cough, exercise intolerance, cyanosis or syncope. Medical management includes weight loss, harness use, cough suppressants, bronchodilators, and anti-inflammatories; humidification and smoke avoidance help. Severe or intrathoracic disease may require extraluminal rings or endoluminal stents, each with specific risks and follow-up needs.
Portosystemic Shunt (PSS) in Yorkshire Terriers: Long-term Liver Health Management (yorkshire-terrier) — Yorkshire Terriers with portosystemic shunts fare best with surgical attenuation when feasible; medical management (dietary protein restriction, lactulose, hepatoprotectants such as SAMe and milk thistle, and intermittent antibiotics) provides palliative control. Long‑term care requires lifelong monitoring (pre‑ and postprandial bile acids, liver enzymes, CBC), weight management, senior‑appropriate hepatic diets, and regular veterinary reassessment to detect complications and optimize prognosis.
Patellar Luxation in Senior Yorkshire Terriers: Grading, Management, and Long-term Joint Health (yorkshire-terrier) — Patellar luxation in senior Yorkshire Terriers is graded I–IV. Mild (I–II) or medically high‑risk seniors often respond to conservative care: weight control, NSAIDs, omega‑3s and chondroprotectants, physical therapy, and assistive devices. Surgical correction is recommended for persistent lameness or Grade III–IV instability but weigh anesthetic risk. Regular orthopedic rechecks, radiographs, and early arthritis management preserve mobility and long‑term joint function.
Legg-Calvé-Perthes Disease in Yorkshire Terriers: Long-term Hip Health After Treatment (yorkshire-terrier) — Yorkshire Terriers with Legg‑Calvé‑Perthes usually regain good long‑term hip function after timely surgical treatment (commonly femoral head and neck ostectomy; total hip replacement is uncommon). With appropriate rehabilitation, weight management, joint supplements, and periodic veterinary monitoring, most Yorkies return to near‑normal activity, although mild lameness or osteoarthritis may develop with age. Early surgery plus consistent physiotherapy gives the best prognosis.
Periodontal Disease in Senior Yorkshire Terriers: Why Dental Health is Critical for Aging Yorkies (yorkshire-terrier) — Periodontal disease affects about 21.1% of Yorkshire Terriers and is the leading health problem in senior Yorkies; untreated it causes pain, tooth loss and can spread bacteria systemically (heart, kidneys). Prevention for aging Yorkies includes daily toothbrushing, veterinary dental cleanings under anesthesia, appropriate dental diets/chews, and biannual oral exams to detect disease early and protect overall health.
Hypoglycemia in Senior Yorkshire Terriers: Prevention, Recognition, and Emergency Response (yorkshire-terrier) — Senior Yorkshire Terriers are prone to hypoglycemia—prevent with frequent small meals (3–4/day), high‑quality protein and complex carbohydrates, regular weight monitoring, and prompt treatment of illness. Watch for weakness, tremors, disorientation, collapse, seizures, or drooling. In an emergency give 1–2 teaspoons of Karo syrup or glucose gel orally if conscious; if unconscious, seek immediate veterinary care and avoid oral administration.

Explore more: Complete Senior yorkshire-terrier Health Guide | Free AI Health Assessment